5th International DNA Sampling Conference

September 16 - 18, 2009
Rimrock Resort Hotel, Banff, Alberta, Canada
Abstracts
  1. Health-related direct-to-consumer genetic testing. A review of companies’ policies with regard to genetic testing in minors
    Pascal Borry, Heidi C Howard, Karine Sénécal, Denise Avard

  2. Race, Risk and Odds Ratios: the Relevance of Personal Genomics for the Non-European
    Sandra Soo-Jin Lee, Ph.D.

  3. The ethics and regulation of biobanks: global consensus and controversies (Results from a worldwide expert consultation)
    Bernice S. Elger (in collaboration with Nikola Biller-Andorno, Alexander Mauron, Agomoni Ganguli-Mitra, Andrea Boggio, and Alexander M. Capron)

  4. Promoting and Subverting Control: The Double-edged Effect of Personalized Genomics 
    Robin Pierce, J.D., Ph.D.

  5. Sequencing, Sequencing and Sequencing
    Dr. Yong Zhang

  6. The Persistence of Race in Biotech Patenting and Drug Development
    Jonathan Kahn, J.D., Ph.D.

  7. Whole genome scanning: resolving clinical diagnosis and management amidst complex data
    Sarah Ali-Khan, Abdallah Daar, Cheryl Shuman, Peter Ray, Stephen Scherer

  8. Evaluation of Genetic Tests and Complex Biomarkers
    Dr Caroline Wright

  9. Motivations and Moral Imperatives of Early Adopters of Personal Genome Services
    Jennifer Fishman, PhD

  10. Human gene patents and genetic testing in the UK: results of an empirical study
    Naomi Hawkins

  11. Genetic Susceptibility Testing for Common Diseases: Findings from the REVEAL (Risk Evaluation & Education for Alzheimer’s Disease) Study
    Scott Roberts, PhD

  12. Using genomic profiling to individualize population cancer screening: an exploratory study of public and professional views
    Dr Brenda J Wilson

  13. Linking Public Engagement and Policy for Human Tissue Biobanking
    Kieran O’Doherty, Michael Burgess, Alice Hawkins

  14. Public Involvement in Genomics and Health: A Comparative Review of Guidelines and Policy Statements
    D Avard, M Stanton-Jean, M Page, G Grégoire

  15. Understanding factors affecting adoption of personalized medicine technologies: Case study of genome expression profiling tests for breast cancer
    Julie N Harris; Stephanie Van Bebber; Kathryn A Phillips

  16. Ethical and Social Challenges in a Whole Genome Sequencing Study of Two Families with a Rare Disease
    Holly K. Tabor, Ph.D.